The one thing Ozempic still can’t fix
The HighlightThe one thing Ozempic still can’t fixAmericans still have a toxic relationship with weight. It’s hurting GLP-1 users.by Dylan ScottAug 4, 2026, 10:00 AM UTCShareGift Olga Aleksandrova for VoxDylan Scott covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health. He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017.GLP-1 drugs promised to usher in a new era of treating obesity as a disease.
- ▪The HighlightThe one thing Ozempic still can’t fixAmericans still have a toxic relationship with weight.
- ▪It’s hurting GLP-1 users.by Dylan ScottAug 4, 2026, 10:00 AM UTCShareGift Olga Aleksandrova for VoxDylan Scott covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health.
- ▪He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017.GLP-1 drugs promised to usher in a new era of treating obesity as a disease.
Vox files mainly under news. We currently carry 127 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Vox |
| Canonical URL | https://www.vox.com/the-highlight/496817/weight-loss-drugs-zepbound-wegovy-glp-1-stigma |
| Publication time | 2026-08-04T06:00:00-04:00 |
| Retrieval time | 2026-08-04T10:07:11.069Z |
| Last seen | 2026-08-04T10:07:11.069Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | jnfWdRFu2cOp · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
The HighlightThe one thing Ozempic still can’t fixAmericans still have a toxic relationship with weight. It’s hurting GLP-1 users.by Dylan ScottAug 4, 2026, 10:00 AM UTCShareGift Olga Aleksandrova for VoxDylan Scott covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health. He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017.GLP-1 drugs promised to usher in a new era of treating obesity as a disease. We could leave behind the anti-fat biases of the past, which blamed obesity on moral failing or personal weakness.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Vox.
Discussion
0 commentsMore from Vox
